{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T11:25:53Z","timestamp":1787570753064,"version":"build-2736575974"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T00:00:00Z","timestamp":1781481600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T00:00:00Z","timestamp":1787529600000},"content-version":"vor","delay-in-days":70,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lipids Health Dis"],"DOI":"10.1186\/s12944-026-02990-7","type":"journal-article","created":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T13:41:16Z","timestamp":1781530876000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Development and validation of continuous cardiovascular-kidney-metabolic syndrome severity score (cCKMS-S) complementing CKM staging"],"prefix":"10.1186","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1520-9344","authenticated-orcid":false,"given":"Safdar","family":"Masoumi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-0900-7770","authenticated-orcid":false,"given":"Mohamadamin","family":"Tarighat-Payma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-5987-9873","authenticated-orcid":false,"given":"Farhad","family":"Shaker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8568-7419","authenticated-orcid":false,"given":"Ladan","family":"Mehran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-1558-7148","authenticated-orcid":false,"given":"Ramin","family":"Assempoor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6470-2517","authenticated-orcid":false,"given":"Fereidoun","family":"Azizi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-4775-3807","authenticated-orcid":false,"given":"Maryam","family":"Adib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9433-9408","authenticated-orcid":false,"given":"Atieh","family":"Amouzegar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4956-1039","authenticated-orcid":false,"given":"Davood","family":"Khalili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,15]]},"reference":[{"key":"2990_CR1","doi-asserted-by":"publisher","unstructured":"GBD 2023 Causes of Death Collaborators. Global burden of 292 causes of death in 204 countries and territories and 660 subnational locations,1990-2023: a systematic analysis for the Global Burden of Disease Study 2023. Lancet. 2025;406(10513):1811\u201372. https:\/\/doi.org\/10.1016\/S0140-6736(25)01917-8.","DOI":"10.1016\/S0140-6736(25)01917-8"},{"key":"2990_CR2","doi-asserted-by":"publisher","unstructured":"GBD 2023 Disease and Injury and Risk Factor Collaborators. Burden of 375 diseasesand injuries, risk-attributable burden of 88 risk factors, and healthy life expectancy in 204 countries and territories, including 660 subnationallocations, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023. Lancet. 2025;406(10513):1873\u20131922. Epub 12 Oct 2025. PMID: 41092926; PMCID: PMC12535840. https:\/\/doi.org\/10.1016\/S0140-6736(25)01637-X. Epub 12 Oct 2025. PMID: 41092926; PMCID: PMC12535840.","DOI":"10.1016\/S0140-6736(25)01637-X"},{"key":"2990_CR3","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1001\/jamacardio.2023.3241","volume":"8","author":"JW Ostrominski","year":"2023","unstructured":"Ostrominski JW, Arnold SV, Butler J, Fonarow GC, Hirsch JS, Palli SR, Donato BMK, Parrinello CM, O\u2019Connell T, Collins EB, et al. Prevalence and Overlap of Cardiac, Renal, and Metabolic Conditions in US Adults, 1999\u20132020. JAMA Cardiol. 2023;8:1050\u201360.","journal-title":"JAMA Cardiol"},{"key":"2990_CR4","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1016\/S2213-8587(14)70102-0","volume":"2","author":"disease Cardiovascular","year":"2014","unstructured":"Cardiovascular disease. chronic kidney disease, and diabetes mortality burden of cardiometabolic risk factors from 1980 to 2010: a comparative risk assessment. Lancet Diabetes Endocrinol. 2014;2:634\u201347.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2990_CR5","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1161\/CIR.0000000000001184","volume":"148","author":"CE Ndumele","year":"2023","unstructured":"Ndumele CE, Rangaswami J, Chow SL, Neeland IJ, Tuttle KR, Khan SS, Coresh J, Mathew RO, Baker-Smith CM, Carnethon MR, et al. Cardiovascular-Kidney-Metabolic Health: A Presidential Advisory From the American Heart Association. Circulation. 2023;148:1606\u201335.","journal-title":"Circulation"},{"key":"2990_CR6","doi-asserted-by":"publisher","first-page":"2042","DOI":"10.1001\/jama.2023.22276","volume":"330","author":"H Larkin","year":"2023","unstructured":"Larkin H. Here\u2019s What to Know About Cardiovascular-Kidney-Metabolic Syndrome, Newly Defined by the AHA. JAMA. 2023;330:2042\u20133.","journal-title":"JAMA"},{"key":"2990_CR7","doi-asserted-by":"publisher","first-page":"1858","DOI":"10.1001\/jama.2024.6892","volume":"331","author":"R Aggarwal","year":"2024","unstructured":"Aggarwal R, Ostrominski JW, Vaduganathan M. Prevalence of Cardiovascular-Kidney-Metabolic Syndrome Stages in US Adults, 2011\u20132020. JAMA. 2024;331:1858\u201360.","journal-title":"JAMA"},{"issue":"11","key":"2990_CR8","doi-asserted-by":"publisher","first-page":"3888","DOI":"10.3390\/jcm14113888","volume":"14","author":"BS Kim","year":"2025","unstructured":"Kim BS, Kim HJ, Kim H, Lee J, Shin JH, Sung KC. Longitudinal changes in cardiovascular-kidney-metabolic syndrome stages and their impact on outcomes: a nationwide cohort study. J Clin Med. 2025;14(11):3888. https:\/\/doi.org\/10.3390\/jcm14113888.","journal-title":"Journal of Clinical Medicine"},{"key":"2990_CR9","doi-asserted-by":"publisher","unstructured":"Yang M, Su C, Chang X, Wang G, Liu J. Data-driven cluster analysis identifies distinct types of cardiovascular-kidney-metabolic syndrome. Eur J Pre Cardiol. 2025;zwaf708. https:\/\/doi.org\/10.1093\/eurjpc\/zwaf708.","DOI":"10.1093\/eurjpc\/zwaf708"},{"key":"2990_CR10","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.metabol.2013.10.006","volume":"63","author":"MJ Gurka","year":"2014","unstructured":"Gurka MJ, Lilly CL, Oliver MN, DeBoer MD. An examination of sex and racial\/ethnic differences in the metabolic syndrome among adults: a confirmatory factor analysis and a resulting continuous severity score. Metabolism. 2014;63:218\u201325.","journal-title":"Metabolism"},{"key":"2990_CR11","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1016\/j.jacc.2016.10.088","volume":"69","author":"MD DeBoer","year":"2017","unstructured":"DeBoer MD, Gurka MJ, Golden SH, Musani SK, Sims M, Vishnu A, Guo Y, Pearson TA. Independent Associations Between Metabolic Syndrome Severity and Future Coronary Heart Disease by Sex and Race. J Am Coll Cardiol. 2017;69:1204\u20135.","journal-title":"J Am Coll Cardiol"},{"key":"2990_CR12","first-page":"77","volume":"2","author":"F Azizi","year":"2000","unstructured":"Azizi F, Madjid M, Rahmani M, Emami H, Mirmiran P, Hadjipour R. Tehran Lipid and Glucose Study (TLGS): rationale and design. Iran J Endocrinol Metabolism. 2000;2:77\u201386.","journal-title":"Iran J Endocrinol Metabolism"},{"key":"2990_CR13","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/j.puhe.2011.02.002","volume":"125","author":"M Barzin","year":"2011","unstructured":"Barzin M, Mirmiran P, Afghan M, Azizi F. Distribution of 10-year risk for coronary heart disease and eligibility for therapeutic approaches among Tehranian adults. Public Health. 2011;125:338\u201344.","journal-title":"Public Health"},{"key":"2990_CR14","doi-asserted-by":"publisher","unstructured":"Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Fruchart JC, James WP, Loria CM, Smith, SC Jr. International diabetes federation task force on epidemiology and prevention, national heart, lung, and blood institute, american heart association, world heart federation, international atherosclerosis society, & international association for the study of obesity. harmonizing the metabolic syndrome: a jointinterim statement of the international diabetes federation task force on epidemiology and prevention; national heart, lung, and blood institute; american heart association; world heart federation; international atherosclerosis society; and international association for the study of obesity. Circulation. 2009;120(16):1640\u201345. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.109.192644.","DOI":"10.1161\/CIRCULATIONAHA.109.192644"},{"key":"2990_CR15","first-page":"243","volume":"13","author":"F Azizi","year":"2010","unstructured":"Azizi F, Khalili D, Aghajani H, Esteghamati A, Hosseinpanah F, Delavari A, Larijani B, Mirmiran P, Mehrabi Y, Kelishadi R, Hadaegh F. Appropriate waist circumference cut-off points among Iranian adults: the first report of the Iranian National Committee of Obesity. Arch Iran Med. 2010;13:243\u20134.","journal-title":"Arch Iran Med"},{"key":"2990_CR16","first-page":"1","volume":"39","author":"A Levey","year":"2002","unstructured":"Levey A, Coresh J, Bolton K, Culleton B, Harvey K, Ikizler T. National Kidney Foundation: K\/DOQI clinical practice guidelines fo r chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002;39:1\u2013266.","journal-title":"Am J Kidney Dis"},{"key":"2990_CR17","doi-asserted-by":"publisher","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","volume":"150","author":"AS Levey","year":"2009","unstructured":"Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150:604\u201312.","journal-title":"Ann Intern Med"},{"key":"2990_CR18","doi-asserted-by":"publisher","first-page":"103596","DOI":"10.1016\/j.eclinm.2025.103596","volume":"90","author":"M Wang","year":"2025","unstructured":"Wang M, Qiao Y, Lin R, Yu Y, Zhao M, Standl M, Magnussen CG, Xi B. Association between cardiovascular-kidney-metabolic syndrome, lifestyle, and all-cause and cause-specific mortality: a prospective cohort study. eClinicalMedicine. 2025;90:103596.","journal-title":"eClinicalMedicine"},{"key":"2990_CR19","doi-asserted-by":"publisher","first-page":"1982","DOI":"10.1161\/CIR.0000000000001191","volume":"148","author":"SS Khan","year":"2023","unstructured":"Khan SS, Coresh J, Pencina MJ, Ndumele CE, Rangaswami J, Chow SL, Palaniappan LP, Sperling LS, Virani SS, Ho JE, et al. Novel Prediction Equations for Absolute Risk Assessment of Total Cardiovascular Disease Incorporating Cardiovascular-Kidney-Metabolic Health: A Scientific Statement From the American Heart Association. Circulation. 2023;148:1982\u20132004.","journal-title":"Circulation"},{"key":"2990_CR20","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1186\/1475-2840-11-128","volume":"11","author":"MJ Gurka","year":"2012","unstructured":"Gurka MJ, Ice CL, Sun SS, DeBoer MD. A confirmatory factor analysis of the metabolic syndrome in adolescents: an examination of sex and racial\/ethnic differences. Cardiovasc Diabetol. 2012;11:128.","journal-title":"Cardiovasc Diabetol"},{"key":"2990_CR21","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1186\/s12933-025-02742-4","volume":"24","author":"Q Zheng","year":"2025","unstructured":"Zheng Q, Cao Z, Teng J, Lu Q, Huang P, Zhou J. Association between atherogenic index of plasma with all-cause and cardiovascular mortality in individuals with Cardiovascular-Kidney-Metabolic syndrome. Cardiovasc Diabetol. 2025;24:183.","journal-title":"Cardiovasc Diabetol"},{"key":"2990_CR22","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/s12933-025-02642-7","volume":"24","author":"P Zhang","year":"2025","unstructured":"Zhang P, Mo D, Zeng W, Dai H. Association between triglyceride-glucose related indices and all-cause and cardiovascular mortality among the population with cardiovascular-kidney-metabolic syndrome stage 0\u20133: a cohort study. Cardiovasc Diabetol. 2025;24:92.","journal-title":"Cardiovasc Diabetol"},{"key":"2990_CR23","first-page":"473","volume":"47","author":"S Mazloomzadeh","year":"2018","unstructured":"Mazloomzadeh S, Rashidi Khazaghi Z, Mousavinasab N. The Prevalence of Metabolic Syndrome in Iran: A Systematic Review and Meta-analysis. Iran J Public Health. 2018;47:473\u201380.","journal-title":"Iran J Public Health"},{"key":"2990_CR24","doi-asserted-by":"publisher","unstructured":"Shafiee A, Kazemian S, Jalali A, Alaeddini F, Saadat S, Masoudkabir F, Tavolinejad H, Vasheghani-Farahani A, Arita VA, Sadeghian S, Boroumand M, Karimi A, Franco OH. Epidemiology and prevalence of dyslipidemia among adult population of tehran: the tehran cohort study. Arch Iran Med. 2024;27(2):51\u201361. https:\/\/doi.org\/10.34172\/aim.2024.10.","DOI":"10.34172\/aim.2024.10"},{"key":"2990_CR25","doi-asserted-by":"publisher","unstructured":"Kheirandish M, Eftekhar E, Azarbad A, Salarpour E, Shahmoradi M, Ghazizadeh S, Malektojari A, Nikeghbali Z, Karimi Lengeh S, Dehghani A. Prevalence of chronic kidney disease and associated factors among the diabetic and prediabetic population in the bandare-kong cohort study: a population-based study. Arch Iran Med. 2024;27(9):470\u20138. https:\/\/doi.org\/10.34172\/aim.31194.","DOI":"10.34172\/aim.31194"},{"key":"2990_CR26","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1186\/s12882-022-02832-5","volume":"23","author":"A Dehghani","year":"2022","unstructured":"Dehghani A, Alishavandi S, Nourimajalan N, Fallahzadeh H, Rahmanian V. Prevalence of chronic kidney diseases and its determinants among Iranian adults: results of the first phase of Shahedieh cohort study. BMC Nephrol. 2022;23:203.","journal-title":"BMC Nephrol"},{"key":"2990_CR27","unstructured":"Centers for Disease Control and Prevention. Chronic Kidney Disease in the United States, 2023. US Department of Health and Human Services, Centers for Disease Control and Prevention; Atlanta: 2023. https:\/\/www.cdc.gov\/kidney-disease\/php\/data-research\/index.html. Accessed 31 March 2026."},{"key":"2990_CR28","doi-asserted-by":"publisher","unstructured":"Martin SS, Aday AW, Allen NB, Almarzooq ZI, Anderson CAM, Arora P, Avery CL, Baker-Smith CM, Bansal N, Beaton AZ, Commodore-Mensah Y, Currie ME, Elkind MSV, Fan W, Generoso G, Gibbs BB, Heard DG, Hiremath S, Johansen MC, Kazi DS. American heart association council on epidemiology and prevention statistics committee and stroke statistics committee. 2025 heart disease and stroke statistics: a report of US and global data from the american heart association. Circulation. 2025;151(8):e41\u2013660. https:\/\/doi.org\/10.1161\/CIR.0000000000001303.","DOI":"10.1161\/CIR.0000000000001303"},{"key":"2990_CR29","doi-asserted-by":"publisher","first-page":"118585","DOI":"10.1016\/j.atherosclerosis.2024.118585","volume":"397","author":"N Li","year":"2024","unstructured":"Li N, Li Y, Cui L, Shu R, Song H, Wang J, Chen S, Liu B, Shi H, Gao H, et al. Association between different stages of cardiovascular-kidney-metabolic syndrome and the risk of all-cause mortality. Atherosclerosis. 2024;397:118585.","journal-title":"Atherosclerosis"},{"key":"2990_CR30","doi-asserted-by":"publisher","unstructured":"Yang Z, Zhou P, Fan F, Hao Y, Zhao W, Wang Z, Deng X, Deng Q, Hao Y, Yang N, Han L, Jia P, Qi Y, Zhang Y, Liu J. A simple score, CKM2S2-BAG, to predict cardiovascular risk with cardiovascular-kidney-metabolic health metrics. iScience. 2025;28(7):112780. https:\/\/doi.org\/10.1016\/j.isci.2025.112780.","DOI":"10.1016\/j.isci.2025.112780"},{"key":"2990_CR31","doi-asserted-by":"publisher","first-page":"e005125","DOI":"10.1161\/CIRCGEN.124.005125","volume":"18","author":"AK Yadalam","year":"2025","unstructured":"Yadalam AK, Liu C, Hui Q, Razavi AC, Sperling LS, Quyyumi AA, Sun YV. Large-Scale Proteomics-Based Risk Score for the Prediction of Incident Cardio-Kidney-Metabolic Disease Risk. Circ Genom Precis Med. 2025;18:e005125.","journal-title":"Circ Genom Precis Med"},{"key":"2990_CR32","doi-asserted-by":"publisher","unstructured":"Qu X, Liu Y, Nie P, Huang L. Association of cardiovascular-kidney-metabolic index with all-cause mortality during hospitalization in critically ill patients: a retrospective cohort study from MIMIC IV2.2. Front Cardiovasc Med. 2024;11:1513212. https:\/\/doi.org\/10.3389\/fcvm.2024.1513212.","DOI":"10.3389\/fcvm.2024.1513212"},{"key":"2990_CR33","doi-asserted-by":"publisher","unstructured":"Tu D, Zuo X, Li P, Wang J. Association between the life's essential 8 health behaviors score and all-cause mortality in cardiovascular-kidney-metabolic syndrome patients. Front Nutr. 2025;12:1612693. https:\/\/doi.org\/10.3389\/fnut.2025.1612693.","DOI":"10.3389\/fnut.2025.1612693"},{"key":"2990_CR34","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1159\/000545451","volume":"56","author":"S Song","year":"2025","unstructured":"Song S, Cai X, Shen D, Hu J, Zhu Q, Ma H, Zhang Y, Ma R, Zhou P, Zhang Z, et al. Relationship between Cumulative Exposure and Time Course of Plasma Aldosterone Concentrations and Chronic Kidney Disease in Hypertensive Patients: A Real-World Cohort Study. Am J Nephrol. 2025;56:641\u201356.","journal-title":"Am J Nephrol"},{"key":"2990_CR35","first-page":"1","volume":"6","author":"PM Hu Lt, Bentler","year":"1999","unstructured":"Hu Lt, Bentler PM. Cutoff criteria for fit indexes in covariance structure analysis: Conventional criteria versus new alternatives. Struct equation modeling: multidisciplinary J. 1999;6:1\u201355.","journal-title":"Struct equation modeling: multidisciplinary J"},{"key":"2990_CR36","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1207\/s15328007sem1103_2","volume":"11","author":"HW Marsh","year":"2004","unstructured":"Marsh HW, Hau K-T, Wen Z. In search of golden rules: Comment on hypothesis-testing approaches to setting cutoff values for fit indexes and dangers in overgeneralizing Hu and Bentler\u2019s (1999) findings. Struct Equ Model. 2004;11:320\u201341.","journal-title":"Struct Equ Model"}],"container-title":["Lipids in Health and Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12944-026-02990-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-026-02990-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-026-02990-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T11:04:21Z","timestamp":1787569461000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12944-026-02990-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,15]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2990"],"URL":"https:\/\/doi.org\/10.1186\/s12944-026-02990-7","relation":{},"ISSN":["1476-511X"],"issn-type":[{"value":"1476-511X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,15]]},"assertion":[{"value":"20 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study conformed to the ethical guidelines of the Helsinki Declaration and was approved by the Human Research Review Committee of the Endocrine Research Center of Shahid Beheshti University of Medical Sciences, Tehran, Iran (IR.SBMU.ENDOCRINE.REC.1401.066). All participants provided written informed consents. The research protocol for NHANES was officially approved by the Institutional Review Board of the National Center for Health Statistics (NCHS IRB). All participants provided informed written consent. As this study utilizes secondary analysis of deidentified, publicly accessible data from NHANES, it was exempt from additional review by the institutional review board according to the standards for secondary data analysis.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"185"}}